Paper Contents
Abstract
ABSTRACT Mucormycosis is a challenging infection to manage because of the lack of available diagnostic and therapeutic options.After aspergillosis and candidiasis, mucormycosis is the third most invasive fungal illness. Fungi that produce zygomycosis are to blame. Rhizopus is the primary species responsible for mucormycosis. Every year, there are roughly 1.7 instances of mucormycosis for every 1,000,000 people . Pain and redness around the eyes and nose, fever, headache, bloody vomiting, black fungal spot on the face, altered mental status, bloody mucus from the nose, local cheek bone pain, one-sided facial pain, numbness, toothache, blurred or double vision, etc. are some signs and symptoms of mucormycosis. The combination of many clinical data and the in vitro isolation of the fungus from clinical samples is necessary for the likely diagnosis of mucormycosis. Rapid identification, mitigating risk factors, surgical resection, debridement, and suitable antifungal treatment are all necessary for the treatment of mucormycosis . People who are diabetic or otherwise weakened, those who have cancer or neutropenia, and those who have just contracted COVID-19 In extreme circumstances, it may spread to the brain and be lethal.KEYWORDS : Causes, COVID-19, Mucormycosis, Prevention, Symptoms, TreatmentINTRODUCTION Mucormycosis is a life threatening Invasive Fungal Disease (IFD) Due to fungi belonging to Mucorales order from class zygomycetes which is post COVID-19 effect 1 Rarely detected, mucormycosis (zygomycosis) is a dangerous and potentially fatal fungal infection. Since mucormycosis is primarily caused by a fungal infection, but it can be caused by a variety of fungi, many researchers refer to it as mucormycosis instead of zygomycosis.2 People who come into contact with environmental fungal spores get affected with mucormycosis. When someone breathes in fungal spores from the air or surroundings, their lungs or sinuses become infected.3 Hematologic malignancies, renal failure, or diabetes mellitus are the clinical manifestations typically associated with mucormycosis. Additionally, rhinocerebral, pulmonary, disseminated, cutaneous (especially burn wounds), and gastrointestinal mucormycosis are affected by this illness. The term mucormycosis was first used by American doctor R.D. Baker. Another name for it is zygomycosis. It is characterized as a sneaky fungal infection brought on by zygomycotic and Mucorales species.4
Copyright
Copyright © 2024 Pratik Bharat shinde. This is an open access article distributed under the Creative Commons Attribution License.
